Latest Stock Buy or Sell?

Today, Barry Schwartz and Jim Cramer - Mad Money commented about whether TWTR-N, SLB-N, VZ-N, AXP-N, SAM-N, MAT-Q, SNAP-N, DHI-N, UNP-N, FCX-N, DOW-N Merged, T-N, TSLA-Q, CRM-N, ABT-N, NFLX-Q, LMT-N, HAL-N, JNJ-N, BAC-N, GS-N, IBM-N, MSFT-Q, AMT-N, MTN-N, NTR-T, CSU-T, FNV-T, AAPL-Q, CHTR-Q, PYPL-Q, AMZN-Q, GOOG-Q, FSV-T, MFC-T, GRT.UN-T, T-T are stocks to buy or sell.

Page 4/7

TOP PICK

Same price as during Covid, which makes no sense. Should report strong results. Upcoming pass sales seem strong. All systems go. Acquires any mountains for sale. Strong management. Lots of free cash. High-end clientele insulated from inflation. Yield is 3.47%. (Analysts’ price target is $294.30)

TOP PICK

Long-life, predictable assets. Some contracts are fixed, but some change with inflation. Nice stream of rising revenues, high margin business. Data usage is increasing, 5G is a benefit. Has raised dividend every quarter for many years. Yield is 2.24%. (Analysts’ price target is $287.89)

Telecommunications

TOP PICK

Valuation 24-25x next year's earnings. One of the top businesses in the world. Ad provider for NFLX. You can't run your life without its products. It's only going to grow from here. Brilliant CEO. Yield is 0.95%. (Analysts’ price target is $347.87)

computer software / processing

DON'T BUY

It reported after the bell today. Not a good report and shares got hammered after hours. The lesson: wait until a company reports, or else you're rolling the dice.

electrical / electronic

BUY

Reported a surprisingly strong quarter by beating revenues and all divisions are doing well, especially trading. Is a cheap stock and pays a great yield. (He used to work here.)

investment companies / funds

COMMENT

Reported a very good quarter today, but the market yawned. The stock deserved more love.

banks

BUY

It reports Tuesday a transitional quarter. JNJ is breaking into a slower-growth consumer products business, and a higher-growth pharma and medical device division. He expects good numbers even in the interim now.

biotechnology / pharmaceutical

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Latest Stock Buy or Sell?

Vail Resorts Inc(MTN-N)

American Tower(AMT-N)

Microsoft(MSFT-Q)

IBM(IBM-N)

Goldman Sachs(GS-N)

Bank of America(BAC-N)

Johnson & Johnson(JNJ-N)